Assessment of the Efficacy of Platelet-Rich Plasma in the Treatment of Traumatic Canine Fractures.

Role of platelet rich plasma (PRP) to promote fracture healing has not been stated clearly. The aim of this prospective clinical study was to evaluate the effectiveness of plasma rich in growth factors (PRGF, derivate PRP) in the treatment of bone fracture occurs naturally in dogs.

With the goal, sixty-five-dog with Goat Serum a radius / ulna or tibia / fracture of the fibula were randomly divided into two groups (PRGF and saline solution (SS) group) and examined at days 0, 7, 14, 21, 28, 35, 42, 49, 56, 60, 63, 70, 120, and 180.

All fractures treated with external skeletal fixation, and pain is controlled with carprofen. Healing was evaluated by physical examination, limb function, radiographic, and by Likert-type questionnaires owner satisfaction. A more rapid healing of fractures observed in PRGF group, with a statistically significant difference against the SS. Swelling at the site of fracture was significantly greater at 14 and 28 days in animals injected with the PRGF, and pain on palpation found in the area in the 28th injection of PRGF in acute fractures accelerate bone healing.

Assessment of the Efficacy of Platelet-Rich Plasma in the Treatment of Traumatic Canine Fractures.

humanin Plasma as a prognostic biomarker for canine myxomatous mitral valve disease: comparison with plasma NT-roBNP.

myxomatous mitral valve disease (MMVD) is a common heart condition found in older dogs. The process of the disease can lead to heart failure (HF). In HF, an increase in reactive oxygen species (ROS) and abnormal mitochondrial activity, and apoptosis, have been reported. Humanin (HN) is a polypeptide having a cardioprotective effect against apoptosis and oxidative stress.

The purpose of this study were (1) to investigate the potential role of plasma HN as cardiac biomarkers to predict disease progression MMVD, and (2) to https://gentaur.ch/ compare the plasma concentrations of HN plasma concentration of NT-pro BNP. Thirty-one dogs were included in this study. The dogs were separated into four groups: Group 1 is a healthy dog (n = 8), Group 2 is MMVD class B (n = 8), group 3 is MMVD class C (n = 8), and Group 4 is MMVD class D (n = 7).

All dogs were given a physical examination, chest radiography, echocardiography, and their blood samples were collected for hematology and blood chemistry analysis. HN plasma and plasma levels of NT-proBNP was also investigated.

A placebo-controlled study comparing the efficacy of intra-articular injections of hyaluronic acid and a novel hyaluronic acid-platelet-rich plasma conjugate in a canine model of osteoarthritis.

The purpose of this study was to assess the efficacy of intra-articular injection of hyaluronic acid (HA) and a novel, where the conjugate of HA with fibrinogen autologous be platelet rich plasma (HA-PRP) in a canine model of osteoarthritis (OA) METHOD : Twelve Donkey Serum beagle dogs underwent unilateral resection of the cranial cruciate ligament (CrCl) of the joint crippling. clinical signs and radiographic OA was confirmed in all dogs 8 weeks after CrCl resection and before treatment. The dogs were randomized into three groups: saline (n = 4), HA (n = 4), and HA-PRP (n = 4). Each dog receives intra-articular injections of each substance into the affected joint in a pre-determined point in time. The dogs were assessed for adverse events during 3 days after each injection and for lameness, pain, range of motion, kinetics, and radiographic OA severity before treatment and 3 months after injection. OA severity as determined by radiographic examination did not differ s...

Canine Plasma

Search This Blog